The company's flagship assay uses whole-genome sequencing to identify patients with high-risk multiple myeloma and determine which patients won't respond to therapies.

A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data presented at the annual meeting of the American Society of Clinical ...

A potential cure for a rare type of blood cancer is currently being used to treat 150 patients at various healthcare centers ...

A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data ...

In the two decades since a young father was diagnosed with multiple myeloma, clinical trials and advances in treating his ...

The following is a summary of “Epidemiology of patients treated for multiple myeloma using a new algorithm in the French ...